Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07520734

Clinical Outcomes After Laser Hemorrhoidoplasty

This single-center prospective observational study aims to evaluate clinical outcomes, postoperative pain scores, complications, and patient satisfaction in adults undergoing laser hemorrhoidoplasty for symptomatic internal hemorrhoidal disease. Additional objectives are to assess the relationship between hemorrhoid stage, dominant presenting symptoms, operative technical details, and postoperative outcomes. No study-specific intervention beyond routine clinical care and follow-up will be performed.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Sanliurfa Education and Research Hospital

Sanliurfa, Şanlıurfa, Turkey (Türkiye)

Location status: Recruiting

Location contact

Vedat Kaplan, MD

CONTACT

[email protected]

+905459045165

About this study

Hemorrhoidal disease is a common benign anorectal condition that can significantly impair quality of life. Conventional excisional techniques may be associated with postoperative pain, bleeding, prolonged recovery, and lower patient satisfaction. Laser hemorrhoidoplasty is a minimally invasive technique based on coagulation and shrinkage of hemorrhoidal tissue without excision. This prospective observational study will be conducted at the General Surgery Clinic of Sanliurfa Education and Research Hospital. Adult patients with symptomatic internal hemorrhoidal disease who are scheduled to undergo laser hemorrhoidoplasty will be enrolled. Preoperative symptoms, hemorrhoid stage, and physical examination findings will be recorded. Intraoperative data will include laser wavelength, total delivered energy, number of hemorrhoidal packages treated, and any additional surgical procedures. Postoperative pain will be assessed at predefined time points using the Visual Analog Scale. Analgesic requirement and duration, length of hospital stay, time to return to daily activities, early complications within 30 days, late complications, symptom status, and recurrence at 6 months will be documented. The study is designed to clarify the clinical role of laser hemorrhoidoplasty and help define appropriate patient selection criteria.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older
  • Symptomatic internal hemorrhoidal disease
  • Scheduled to undergo laser hemorrhoidoplasty
  • Willingness to participate and provision of informed consent

Exclusion criteria

  • Grade IV hemorrhoidal disease
  • Acute thrombosed hemorrhoids
  • Additional anorectal pathology such as anal fissure, fistula, or perianal abscess
  • History of inflammatory bowel disease or colorectal malignancy
  • Previous major anal surgery'

Treatment and study plan

Laser Hemorrhoidoplasty

Procedure

Laser-based minimally invasive treatment of internal hemorrhoidal disease performed as part of routine clinical care.

Primary outcomes

  1. Postoperative pain score

    Time frame: At 6 hours, 24 hours, and 1 week after surgery

    Postoperative pain assessed using a 0 to 10 Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain; higher scores indicate worse pain.

Secondary outcomes

  1. Duration of postoperative analgesic use

    Time frame: From the day of surgery through 30 days after surgery

    Duration of postoperative analgesic use, measured in days.

  2. Length of hospital stay

    Time frame: From the day of surgery to hospital discharge, up to 7 days

    Postoperative hospital stay, measured in days from the date of surgery to the date of discharge.

  3. Incidence of predefined early postoperative complications

    Time frame: Within 30 days after surgery

    Number and proportion of patients who develop any predefined early postoperative complication within 30 days after laser hemorrhoidoplasty. Predefined complications include postoperative bleeding, urinary retention, anal thrombosis, infection, severe pain, and anal stenosis. Patients without any of these events will be classified as having no complication.

  4. Time to return to daily activities

    Time frame: Up to 30 days after surgery

    Time required to return to usual daily activities, measured in days.

  5. Patient satisfaction

    Time frame: Up to 3 months after surgery

    Patient-reported satisfaction after laser hemorrhoidoplasty.

Study contacts

Contact information is provided by the study sponsor or research team.

Vedat Kaplan, MD

CONTACT

[email protected]

+905459045165

Sponsors and collaborators

Lead sponsor

Sanliurfa Education and Research Hospital

Other Gov

Registry information

Official study title

Clinical Outcomes, Pain Scores, and Patient Satisfaction in Patients Undergoing Laser Hemorrhoidoplasty: A Prospective Observational Study

Acronym: LHP

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Apr 9, 2026
Registry last updated
Jul 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.